Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Silicon Valley Looks to Disrupt American Healthcare

Numerous Silicon Valley giants are moving to disrupt the American healthcare industry. Massive inefficiencies and rising costs have created a unique opportunity for the tech giants to undercut health mainstays and change the industry for good. Amazon is planning to partner with JPMorgan Chase and Warren Buffett, though the purpose and details of the collaboration…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Numerous Silicon Valley giants are moving to disrupt the American healthcare industry. Massive inefficiencies and rising costs have created a unique opportunity for the tech giants to undercut health mainstays and change the industry for good.

Amazon is planning to partner with JPMorgan Chase and Warren Buffett, though the purpose and details of the collaboration is unclear. Meanwhile, Apple is preparing to open a line of medical clinics throughout California, and Google is planning to jump into the Medicaid market, beginning in Rhode Island. Uber has set its sights on ambulances, offering those in need a more expensive and on-demand service to get to the care they need.

Observers have noted that none of these major tech players are directly competing with one another in their new healthcare ventures. Many are focusing on reducing costs for their own employees alone. What they all have in common is the enormity of their challenge. The American healthcare industry is a complex and bloated sector, with as many obstacles as there are paths to profit. Silicon Valley’s track record for disrupting and revolutionizing outdated industries is impressive, but the sheer size of healthcare (upwards of $3 trillion) could finally overwhelm the notorious disruptors.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's Healthcare expertise into the articles, video, and social content B2B marketing buyers in your industry are searching for. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Leading with Purpose: Dr. David Foster on Faith, Healthcare Leadership, and Physician Collaboration

Dr. David Foster discusses the importance of faith in healthcare leadership and the role of physician collaboration. The conversation emphasizes how values-driven leadership can positively impact patient care. The dialogue also explores the significance of integrating personal beliefs in professional settings.

  • 01Values-driven leadership can significantly enhance patient care.
  • 02Integrating personal beliefs in professional settings can benefit healthcare leadership.
  • 03Collaboration among physicians is crucial for effective healthcare leadership.

Aug 4, 2026

Digital health VC hits $7.4B in H1 2026 as AI agents, chronic care, and workforce tools capture mega-deal capital

Digital health VC hits $7.4B in H1 2026 as AI agents, chronic care, and workforce tools capture mega-deal capital

Digital health venture funding reached $7.4B in the first half of 2026, with significant investments in AI agent platforms and chronic care tools. Mega-deals of over $100 million were a key driver of the funding surge.

  • 01Digital health VC funding hit $7.4 billion in the first half of 2026.
  • 02Mega-deals in AI agent platforms and chronic care tools exceeded $100 million.
  • 03AI, chronic care, and workforce tools dominate digital health investments.

Aug 4, 2026

Pharma M&A surges on a single day: KKR's $5.7B Integer deal, Curium's $8B Lantheus buy, and AstraZeneca's blocked megamerger signal a restructuring market

Pharma M&A surges on a single day: KKR's $5.7B Integer deal, Curium's $8B Lantheus buy, and AstraZeneca's blocked megamerger signal a restructuring market

Three significant transactions occurred in the pharmaceutical and medtech sectors on August 3, highlighting a split M&A market. While mid-market buyouts such as KKR's acquisition of Integer Holdings and Curium's purchase of Lantheus proceeded, larger megamergers like AstraZeneca's faced obstacles. This suggests a trend towards restructuring within the industry.

  • 01KKR acquired Integer Holdings for $5.7 billion.
  • 02Curium purchased Lantheus in an $8 billion deal.
  • 03AstraZeneca's megamerger attempt was blocked.

Aug 3, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512